Neurogene Inc. NASDAQ:NGNE

Neurogene stock price today

$19.7
-3.26
-14.24%
Financial Health
0
1
2
3
4
5
6
7
8
9

Neurogene stock price monthly change

-46.05%
month

Neurogene stock price quarterly change

-46.05%
quarter

Neurogene key metrics

Market Cap
461.61M
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-2.83
Revenue
N/A
EBITDA
-69.61M
Income
-48.80M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Neurogene stock price history

Neurogene stock forecast

Neurogene financial statements

Average Price Target
Last Year

$52

Potential upside: 163.95%

Based on estimate of 3 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Neurogene Inc. (NASDAQ:NGNE): Profit margin
Jun 2023 0 -11.86M
Sep 2023 0 -4.52M
Dec 2023 0 -15.50M
Mar 2024 0 -16.92M
Neurogene Inc. (NASDAQ:NGNE): Debt to assets
Jun 2023 85794000 254.84M 297.05%
Sep 2023 89586000 14.35M 16.02%
Dec 2023 222573000 36.54M 16.42%
Mar 2024 195350000 24.57M 12.58%
Neurogene Inc. (NASDAQ:NGNE): Cash Flow
Jun 2023 -4.10M -374.61K -295.27K
Sep 2023 -4.29M -1.61M -1.24K
Dec 2023 -29.51M 16.68M 92.00M
Mar 2024 -21.65M 29.93M -6.52M

Neurogene alternative data

Neurogene Inc. (NASDAQ:NGNE): Employee count
Feb 2024 82
Mar 2024 91
Apr 2024 91
Jun 2024 91
Jul 2024 91

Neurogene other data

Neurogene Inc. (NASDAQ:NGNE): Insider trades (number of shares)
Period Buy Sel
Nov 2024 120270 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
SAMSARA BIOCAPITAL GP, LLC 10 percent owner
Common Stock 2,000 $27.5 $55,000
Purchase
SAMSARA BIOCAPITAL GP, LLC 10 percent owner
Common Stock 15,219 $26.73 $406,804
Purchase
SAMSARA BIOCAPITAL GP, LLC 10 percent owner
Common Stock 10,803 $26.01 $280,986
Purchase
SAMSARA BIOCAPITAL GP, LLC 10 percent owner
Common Stock 20,748 $24.91 $516,833
Purchase
CVIJIC CHRISTINE MIKAIL officer: President and CFO
Common Stock 24,000 $20.48 $491,400
Purchase
MCMINN RACHEL director, officer: Chief Execut..
Common Stock 47,500 $20.4 $969,000
Friday, 27 December 2024
prnewswire.com
Thursday, 26 December 2024
accesswire.com
Tuesday, 17 December 2024
accesswire.com
Monday, 16 December 2024
accesswire.com
Sunday, 15 December 2024
accesswire.com
Friday, 13 December 2024
accesswire.com
Wednesday, 11 December 2024
accesswire.com
Tuesday, 3 December 2024
prnewswire.com
Thursday, 28 November 2024
accesswire.com
Wednesday, 27 November 2024
accesswire.com
accesswire.com
Tuesday, 26 November 2024
accesswire.com
accesswire.com
accesswire.com
Monday, 25 November 2024
prnewswire.com
accesswire.com
accesswire.com
Sunday, 24 November 2024
accesswire.com
Friday, 22 November 2024
accesswire.com
accesswire.com
Thursday, 21 November 2024
accesswire.com
accesswire.com
Wednesday, 20 November 2024
accesswire.com
accesswire.com
accesswire.com
Tuesday, 19 November 2024
accesswire.com
accesswire.com
Monday, 18 November 2024
prnewswire.com
businesswire.com
benzinga.com
  • What's the price of Neurogene stock today?

    One share of Neurogene stock can currently be purchased for approximately $19.7.

  • When is Neurogene's next earnings date?

    Unfortunately, Neurogene's (NGNE) next earnings date is currently unknown.

  • Does Neurogene pay dividends?

    No, Neurogene does not pay dividends.

  • How much money does Neurogene make?

    Neurogene has a market capitalization of 461.61M.

  • What is Neurogene's stock symbol?

    Neurogene Inc. is traded on the NASDAQ under the ticker symbol "NGNE".

  • What is Neurogene's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Neurogene?

    Shares of Neurogene can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Neurogene have?

    As Jul 2024, Neurogene employs 91 workers.

  • When Neurogene went public?

    Neurogene Inc. is publicly traded company for more then 11 years since IPO on 7 Mar 2014.

  • What is Neurogene's official website?

    The official website for Neurogene is neurogene.com.

  • Where are Neurogene's headquarters?

    Neurogene is headquartered at 535 W 24th Street, New York, NY.

  • How can i contact Neurogene?

    Neurogene's mailing address is 535 W 24th Street, New York, NY and company can be reached via phone at (877) 237-5020.

  • What is Neurogene stock forecast & price target?

    Based on 3 Wall Street analysts` predicted price targets for Neurogene in the last 12 months, the avarage price target is $52. The average price target represents a 163.95% change from the last price of $19.7.

Neurogene company profile:

Neurogene Inc.

neurogene.com
Exchange:

NASDAQ

Full time employees:

91

Industry:

Biotechnology

Sector:

Healthcare

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.

535 W 24th Street
New York, NY 10011

CIK: 0001404644
ISIN: US64135M1053
CUSIP: 64135M105